Viewing nowAdbon Tablet 70mg (Sodium Alendronate Trihydrate)
Sodium Alendronate Trihydrate 91.37mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 200501583 · Notified 2005.03.31 · Insurance code 647801610
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in postmenopausal women and men. Osteoporosis is a condition where bone density decreases, leading to an increased risk of fractures, and this drug helps strengthen bones and reduce the risk of fractures. Therefore, it is effective in preventing fractures due to osteoporosis.
○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medications may reduce the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and diminish its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to ensure that it reaches the stomach quickly and to reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine, and remain upright until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). If the patient's dietary intake of calcium and vitamin D is inadequate, supplements should be taken (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of use. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after taking this medicine for 3 ∼ 5 years. Patients who discontinue treatment should be reassessed regularly for their risk of fracture. ○ If you miss a dose on the scheduled day, take 70 mg the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day.
This drug can irritate the gastric mucosa, so patients with gastrointestinal issues such as esophageal diseases, gastritis, or duodenitis should be cautious. After taking, serious side effects such as esophagitis or esophageal ulcers may occur, so if symptoms such as dysphagia, chest pain, or heartburn develop, immediately stop taking the medication and consult a doctor. Take with a sufficient amount of water and do not lie down for at least 30 minutes after taking. To reduce esophageal irritation, do not chew or suck on the tablet, and take it first thing in the morning on an empty stomach. Since the efficacy of this drug may decrease with inadequate intake of calcium and vitamin D, it is advisable to take supplements if necessary. Particularly, patients with severely impaired kidney function, pregnant or breastfeeding women, and patients with certain genetic disorders should not take this drug. Additionally, this drug may cause side effects such as bone, muscle, or joint pain, dyspepsia, abdominal pain, nausea, etc., so consult a doctor if symptoms are severe. Do not take this drug together with calcium supplements or antacids; maintain at least a 30-minute interval. The risk of gastrointestinal irritation may increase when used concurrently with non-steroidal anti-inflammatory drugs, so caution is necessary. Safety and efficacy have not been established for children and adolescents under 18 years of age. Elderly patients can take this drug; however, some elderly individuals may be more sensitive to medications, so caution is advised. In case of overdose, symptoms like hypocalcemia and gastrointestinal disturbances may occur, so immediately visit a medical facility. This drug should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to prevent air and moisture entry. The temperature should be maintained between 15 to 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for a longer period.
White oval tablet
4 tablets (4 tablets/PTP*1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSodium Alendronate Trihydrate 91.37mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Sodium Alendronate 91.37mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Sodium Alendronate 91.37mg
Tablet · Prescription medication
(Co., Ltd.) Jungkundang

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.